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Interferon (IFN)  induced  during  virus  infection may limit  disease  by direct 
mediation of antiviral effects in cells or by modulation of the host response. IFN 
induces  the  activation  and  proliferation of natural  killer (NK)  cells (1-3),  en- 
hances macrophage-mediated phagocytosis (4) and cytotoxicity (5), and may be 
required for the generation of cytotoxic T  cells (CTL) (6).  IFN also alters the 
membranes of target cells,  rendering them resistant  to NK cell-mediated lysis 
(7) and inducing the expression of cell surface proteins, including major histo- 
compatibility (MHC) antigens (8, 9). CTL recognize viral antigens in the context 
of syngeneic class I MHC antigens (10). It is thus possible, though not previously 
shown, that IFN may condition target cells for increased susceptibility to antiviral 
CTL  by  inducing  MHC  antigen  expression.  We  show  here  that  IFN  greatly 
enhances the susceptibility of virus-infected mouse embryonic fibroblasts (MEF) 
to  CTL-mediated  lysis,  and  that  this  correlates  with  increased  expression  of 
mouse MHC (H-2) antigens. 
Materials and Methods 
Animals.  C57BL/6 and BALB/c mice were purchased from The Jackson Laboratory, 
Bar Harbor, ME.  C3H/St mice were purchased from West Seneca Laboratories, West 
Seneca, NY. Mice of either sex, 6-16 wk old, were used in these experiments. 
Cells.  Mouse embryonic fibroblasts (MEF) from BALB/c (H-2  d) or C57BL/6 (H-2  b) 
mice were  prepared as  described (16),  and  maintained  in  minimal  essential  medium 
(MEM) (Gibco Laboratories, Grand Island, NY) supplemented with antibiotics, glutamine, 
and  10%  heat-inactivated fetal bovine serum  (FBS)  (M.  A.  Bioproducts, Walkersville, 
MD). The continuous cell lines L-929 (H-2  k) and MC57G (H-2  b) were also maintained on 
MEM.  Baby  hamster  kidney (BHK) cells  were  grown  in  Dulbecco's  MEM  with  10% 
tryptose phosphate broth as an additive. 
Viruses.  Lymphocytic choriomeningitis virus (LCMV), Armstrong strain, was grown 
in BHK cells. Vaccinia virus (VV), strain WR, was grown in mouse L-929 cells. 
Treatment of Target Cells.  Target cells were dispensed in 60 mm Petri dishes and some 
were infected with LCMV at a multiplicity of infection (MOI) of 0.05 and incubated for 
2 d. VV was added at an moi of 5.0 and incubated for I0 h. IFN-/3 (Lee Biomolecular, 
San Diego, CA) was then added to some of the virus-infected and uninfected cultures at 
10,000  U/ml,  and the  incubation was  continued for an  additional  12-24  h.  In  some 
experiments, supernatant  containing 64  U/ml  IFN-3,  generated from concanavalin A 
(Con  A)-stimulated  spleen  cells  was  added.  The  cells  were  then  used  as  targets  in 
cytotoxicity assays. 
Cytotoxicity Assay.  Assay medium was RPM 1 1640 medium supplemented with 0.1  M 
Hepes (Sigma Chemical Co., St. Louis, MO),  10% FBS, glutamine, and antibiotics. The 
assay  was  performed  as  described  (1).  Briefly,  target  cells  labeled  with  100  #Ci 
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[57Cr]sodium chromate (New England Nuclear, Boston, MA) for 1 h at 37°C were washed 
and mixed with various numbers of effector cells in round-bottomed microtiter wells at 
104 target cells per well. For spontaneous release determination, medium was added to 
the wells; 1% Nonidet P-40  was added for maximum release determination. Plates were 
incubated for 6-8 h at 37 °C in a humidified atmosphere of 5% CO2, 95% air. At the end 
of the incubation, plates were centrifuged at 200 g for 5 rain, and 0.1 ml of the supernatant 
was collected and counted for radioactivity in a Beckman Gamma 5500 Counter (Beckman 
Instruments, Palo Alto, CA). Data are expressed as percent specific release:  100 × [(cpm 
experimental -  cpm spontaneous)/(cpm maximum -  cpm spontaneous)]. Spontaneous 
release was 16-28%. Standard deviations of quadruplicate replica samples were <10% of 
the mean, and are not shown. 
Quantitation of Cell Surface Antigens.  For analysis of LCMV surface antigens, 5 ×  10  ~ 
target cells were treated with mouse anti-LCMV antiserum at a final dilution of 1:50 in a 
volume of 150 ~1, and incubated 45 rain at 4°C. The cells were washed and then treated 
with 100 ~1 fluorescein isothiocyanate-conjugated goat anti-mouse Ig (Cappell  Labora- 
tories, Cochranville, PA) at 1:40 for 45 min at 4°C. The cells were washed and subjected 
to analysis by flow cytometry. Surface H-2 antigens were quantitated by the same method, 
using congenic anti-H-2  b (B10.A anti-B10) or anti-H-2  a (B10  anti-B10.D2) antisera ob- 
tained from Dr. Rolf Kiessling, Karolinska Institute, Stockholm, Sweden, and used at a 
final dilution of 1:60. 
Results and Discussion 
We  inoculated  C57BL/6  (H-2b),  C3H/St  (H-2k),  or  BALB/c  (H-2 d)  mice 
intraperitoneally with 107 plaque-forming units (PFU) VV strain WR or 8 ×  104 
PFU LCMV, strain Armstrong. 7 d  later, the mice were killed and their spleen 
leukocytes were  used as CTL effectors in  cytotoxicity assays.  The  target cells 
were low-passage C57BL/6 or BALB/c MEF, or the continuous cell lines, L-929 
(H-2 k) and MC57G (H-2b). Cells were either untreated, treated with IFN, infected 
with  VV  or  LCMV,  or  infected and  later  tr.eated  with  IFN,  as  described  in 
Materials and  Methods.  After radiolabeling  with  chromate,  we  used  them  as 
targets for CTL. The results in Fig.  1, A-C indicate that pretreatment of VV- 
or  LCMV-infected  MEF  with  10,000  U/ml  IFN-13 resulted  in  a  substantial 
increase in the sensitivity of these targets to lysis by virus-specific CTL. IFN-i3 
did not enhance the low levels of lysis observed with uninfected cells. Pretreat- 
ment  with  supernatants  containing  64  U/ml  IFN-7  generated  from  Con  A- 
stimulated spleen cells yielded virtually identical results (data not shown).  Lysis 
of the virus-infected IFN-/3-treated targets was mediated by CTL, as it was H-2 
restricted, and eliminated by pretreating the effectors with monoclonal anti-Thy- 
1.2  antibody and complement (C)  (data not shown).  In contrast  to the results 
with T  cell  killing,  IFN-/3 induced protection  of both  uninfected and  LCMV- 
infected target cells against iysis by activated NK cells (Fig.  1, D  and H).  This 
demonstration of IFN-mediated protection against NK cells indicates that IFN 
did not increase target cell sensitivity to lysis in general.  Further,  IFN-treated 
cells did not exhibit greater spontaneous release of label, and they were equally 
resistant to anti-LCMV antibody plus C-mediated lysis as compared with controls 
(data not shown). 
We observed IFN-induced enhancement of sensitivity to CTL lysis with both 
C57BL/6 and BALB/c MEF,  which suggests that this phenomenon may be a 
general property of low-passage MEF (Fig.  1, A-C).  However, IFN-/3 pretreat- 
ment  of virus-infected continuous  cell  lines,  i.e.,  LCMV-infected  L-929  (Fig. 
1E),  VV-infected L-929  (data  not shown),  LCMV-infected MC57G  (Fig.  1 F), BUKOWSKI  AND  WELSH  BRIEF  DEFINITIVE  REPORT  259 
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FIGURE  I.  Enhancement  of LCMV- and VV-specific ~I" cell-mediated lysis by pretreatment 
of MEF with IFN. (0----0) Virus-infected targets. (0--.0) Virus-infected targets pretreated with 
IFN-3.  (O---O)  Uninfected  targets.  (O--O)  Uninfected  targets  pretreated  with  IFN-3.  (A) 
BALB/c day-7 LCMV-immune spleen cells were used as CTL effectors against LCMV-infected 
or  uninfected  BALB/c MEF. (B)  Same as A, except CTL were C57BL/6 and targets  were 
C57BL/6 MEF.  (C) C57BL/6 day-7  VV-immune spleen cells were used as effectors against 
VV-infected or uninfected C57BL/6 MEF. (D) C57BL]6 spleen cells 3 d after LCMV infection 
were used as a source of NK cell effectors (1) against LCMV-infected or uninfected C57BL/6 
MEF.  (E)  C3H/St  day-7  LCMV-immune  spleen  cells were  used  as CTL  effectors  against 
LCMV-infected or uninfected  L-929 cells.  (F) C57BL/6 day-7  LCMV-immune spleen cells 
were  used as CTL  effectors  against  LCMV-infected  or uninfected  MC57G target cells.  (G) 
Same as C, except targets were MC57G. (H) Same as D, except targets were MC57G. 
VV-infected MC57G (Fig.  1 G), did not enhance their sensitivity to lysis by CTL. 
This result was anticipated,  as these targets are already highly  sensitive to lysis 
by CTL. 
The  structures  recognized  by  virus-specific  CTL  are  virus-induced  surface 
proteins in association with class I MHC antigens (10). IFN is known to enhance 
the cell surface expression of both MHC (8, 9) and certain viral antigens (11) in 
some systems. To investigate the possibility that IFN was altering surface antigen 
expression on MEF, we quantitated surface H-2 and LCMV antigens by treating 
MEF with fluorescein-labeled antibodies and analyzing the cells by flow cytome- 
try. IFN-3 pretreatment of MEF had no significant effect on the expression of 
surface  LCMV  antigens  (data  not  shown),  but  both  uninfected  and  LCMV- 
infected MEF had substantial  increases in surface H-2 expression (Fig.  2, A, C, 
and  F).  Analysis  of the continuous  cell  line  MC57G  also  showed  that  surface 260  BUKOWSKI  AND  WELSH  BRIEF  DEFINITIVE  REPORT 
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FIGURE 2.  Surface  expression  of  H-2  antigens.  (A)  LCMV-infected  C57BL/6  MEF.  (B) 
LCMV-infected MC57G. (C) Uninfected C57BL]6 MEF. (D) Uninfected MC57G. (E) Unin- 
fected C57BL/6 MEF. (F) Uninfected BALB/c MEF. 
expression of LCMV antigens remained unchanged after IFN-3 pretreatment 
(data not shown), but, in contrast to the MEF, MC57G cells had similar levels of 
surface H-2 antigens whether or not they were pretreated with IFN-3 (Fig. 2, B 
and D).  Infection with  LCMV  had  only a  minor effect on  this  observation. 
MC57G  cells were sensitive to  other IFN-mediated effects, as  IFN  protected 
these cells from NK cell-mediated lysis (Fig.  1 H). The level of surface H-2 on 
the untreated MC57G cells was similar to that on IFN-treated MEF, suggesting 
that  MC57G  cells  may already express  a  level  of surface H-2  antigens  high 
enough for efficient association with viral antigens to be good targets for CTL. 
Treatment of MEF (Fig. 2E) or MC57G cells (data not shown) with supernatants 
containing 64 U/ml IFN-~, generated from Con A-stimulated spleen cells yielded 
nearly identical results. 
IFN-induced enhancement of surface H-2 expression was dose dependent, and 
supernatants containing IFN-~ were more potent than IFN-3 as inducers of H-2 
antigens (Table  I),  in  agreement with previously published observations (12). 
Similarly, fewer units of IFN-y were needed to render targets more susceptible 
to iysis by CTL (Table I). 
Since  MHC  class  I-restricted,  virus-specific T  cells are known to  eliminate 
virus in vivo (13), it is possible that IFN enhances this process by increasing the 
sensitivity of virus-infected cells to lysis by CTL.  The source of the IFN could 
be either virus-induced IFN-a or IFN-3,  or IFN-~" produced by T  cells upon 
recognition of a target (14). T  cell-produced IFN-3,  may locally enhance MHC 
expression in focal areas of infection, thereby increasing the sensitivity of T  cell 
recognition of virus-infected tissue. Recent findings (15) show that IFN treatment 
of mice infected intracranially with  LCMV  leads to increased mortality. Since 
death  in  this  system  has  been  shown  to  be  caused  by  virus-specific T  cell- 
dependent  destruction  of brain  tissue  (16),  it  is  possible  that  IFN  may  be 
enhancing H-2 antigen expression on the surface of brain tissue (12), leading to BUKOWSKI  AND  WELSH  BRIEF  DEFINITIVE  REPORT  261 
TABLE  I 
Enhancement of H-2 Expression and of Sensitivity to CTL-mediated 
Lysis by Various Concentrations  of lFN-13 and IFN-v 
Percent cells 
Mean fluores-  fluorescing  Percent spe- 
cific SlCr re-  IFN  cence intensity  above chan- 
lease  nel 175 
IFN-/~ 
U]ml 
10,000  1,038 (426)  78 (45)  41  (31) 
3,333  1,120 (508)  77 (44)  39  (29) 
1,111  1,120(508)  80(47)  35  (25) 
370  1,078 (466)  80 (47)  36  (26) 
123  893 (281)  69 (36)  29  (19) 
41  860 (248)  61 (28)  29  (19) 
14  739 (127)  49 (16)  27  (17) 
4.6  712(100)  46 (13)  27  (17) 
1.5  660 (48)  40 (7)  15  (5) 
0.0  612 (0)  33 (0)  9.9(0) 
IFN-3'  64  1,302 (690)  85 (52)  35  (25) 
21  963 (351)  68 (35)  34  (24) 
7.1  1,000 (388)  70 (37)  33  (23) 
2.4  963 (351)  70 (37)  29  (19) 
0.8  ND*  ND  25  (15) 
0.3  797 (185)  54 (21)  29  (19) 
0.09  686(74)  44(11)  17  (7) 
0.00  612 (0)  33 (0)  9.9 (0) 
Various concentrations of IFN-/3 and Con  A  supernatant containing 
IFN-~' activity were added to LCMV-infected MEF. 24 h later, the MEF 
were used as targets in a CTL assay and also quantitated for surface H- 
2 expression by flow cytometry as described in Materials and Methods. 
Fluorescence is expressed as the percentage of cells fluorescing above 
channel 175, or as the mean fluorescence intensity of all the cells in the 
sample. 61 channels are one order of magnitude of fluorescence inten- 
sity; the gain was set at 1.7. The numbers in parentheses represent the 
differences between the  IFN-treated cells  and the  untreated control 
cells. 
* ND, not done. 
more  destruction  of  LCMV-infected  cells  by  virus-specific  T  cells.  This  IFN- 
induced enhancement  of MHC  antigens on virus-infected cells may thus augment 
T  cell-dependent  immunopathology  as  well  as  T  cell-dependent  clearance  of 
virus. 
Summary 
Interferon  (IFN)  pretreatment  of low-passage  mouse  embryonic  fibroblasts 
(MEF)  infected  with lymphocytic  choriomeningitis  virus or  vaccinia  virus ren- 
dered these cells two to three times more susceptible  to lysis by H-2  restricted, 
virus-specific cytotoxic  T  lymphocytes  (CTL) than control,  virus-infected  MEF. 
The increased sensitivity to lysis correlated  with increased expression of surface 
H-2 antigens, but not viral antigens. Continuous cell lines already highly sensitive 
to CTL-mediated lysis and already expressing high levels of surface H-2 antigens 
were unaffected by IFN pretreatment.  These results suggest that IFN treatment, 
by increasing  surface  H-2  levels,  may result in increased  association  of surface 
H-2  and  virus  antigens,  leading  to  enhanced  recognition  and  lysis  by  virus- 262  BUKOWSKI  AND  WELSH  BRIEF  DEFINITIVE REPORT 
specific CTL. 
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